$ENS

EnerSys to acquire Ultralife for $320 million in cash deal

EnerSys (ENS) to acquire Ultralife (ULBI) for $320M in cash, offering $16.00 per share, a 166% premium. Ultralife generated $191M revenue in 2025. Deal expected to close Q1 2027, with $15M-$20M annual synergies. Both boards approved. Funded via cash on hand.

Original reporting
Published Oct 27, 2026, 8:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ENS
Bullish
high confidence
Mentioned
$ENS · $ULBI
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ENSBullishHigh
01

Why it matters

The deal adds manufacturing capacity and technology to EnerSys, while ULBI shareholders receive a substantial cash premium.

02

Market read

A sizable, premium cash acquisition that is likely to move both ENS and ULBI stocks and reshape the defense battery market.

03

What to watch

Regulatory approval risk and potential antitrust scrutiny could delay or alter deal terms.

Relevance 9/10Novelty 9/10Timing: immediate today

Background

EnerSys, a leading provider of industrial batteries, seeks to expand its defense power portfolio through the acquisition of Ultralife, a specialist in military communications batteries.

Company-level read

Ticker impact

$ENSBullishHigh confidence
Context

EnerSys announced a definitive agreement to acquire Ultralife for $320 million, a 166% premium, indicating a material M&A event for ENS.

Expected impact

likely upward pressure as the market prices in the strategic fit and earnings accretion.

Evidence & confidence

Deal size and premium suggest investors will bid up ENS shares on expected growth in the defense power segment.

$ULBIBullishHigh confidence
Context

Ultralife is the target of EnerSys' $320 million cash acquisition at $16.00 per share, a 166% premium to its recent price.

Expected impact

likely short‑term upside as the tender offer price exceeds current market levels.

Evidence & confidence

The announced cash offer at a large premium should drive ULBI's share price toward the $16.00 tender price.

Market effects

Consolidates the defense battery market, potentially pressuring peers in the industrial battery space.

Strengthens U.S. defense supply chain, may affect related defense contractors.

Highlights continued M&A activity in the battery sector amid rising defense spending.

Counterpoint

If integration costs exceed expectations, ENS could face margin pressure despite the premium.

Key entities

  • Shawn O’Connell

    President and CEO of EnerSys, quoted on strategic fit.

  • Michael Manna

    President and CEO of Ultralife, quoted on shareholder value.

Related articles

$ENSHighAI 9/10

EnerSys to Acquire Ultralife for $16 Per Share in Cash

EnerSys (ENS) agreed to acquire Ultralife for $16 per share in cash. The deal, subject to regulatory approvals, includes support from shareholders holding 40.3% of Ultralife's shares. The tender offer is expected to start within 10 business days and may close by April 27, 2027, with possible extensions.

$ENSHighAI 9/10

EnerSys to acquire Ultralife for $320 million in cash

EnerSys (ENS) agreed to acquire Ultralife (ULBI) for $320 million in cash, including debt. Ultralife shareholders will receive $16.00 per share, a 166% premium over Monday's closing price. The deal, approved by both boards, is expected to close in Q1 2027. EnerSys will finance the acquisition with available cash. Both companies' CEOs cited strategic benefits and value creation.

$ENSLowAI 8/10

EnerSys (ENS) Down 9.3% Since Last Earnings Report: Can It Rebound?

EnerSys (ENS) shares fell 9.3% since its last earnings report, despite beating Q1 estimates with $3.66 EPS and $936M sales. Strength in NIS and PPS segments drove growth, while IMS saw declines. The company guided higher for Q2, expecting $955M-$995M sales and $3.15-$3.25 EPS. Analysts have raised estimates, giving ENS a Zacks Rank #2 (Buy).

$ARRYMedAI 8/10

Spotting Winners: Array (NASDAQ:ARRY) And Renewable Energy Stocks In Q2

Array (ARRY) fell 22.5% post-earnings, trading at $4.37. Bloom Energy (BE) surged 27.1% after reporting $1.07B revenue, up 166% YoY, beating estimates. Fluence Energy (FLNC) dropped 26.6% with $649.8M revenue, missing expectations. EnerSys (ENS) declined 3.3% despite beating EPS estimates. First Solar (FSLR) fell 3.1% after mixed results.

$ENSHighAI 8/10

EnerSys (ENS) Q1 2027 Earnings Call Transcript

EnerSys (ENS) reported Q1 2027 net sales of $935.6M (+4.8% YoY) and adjusted EPS of $3.66 (+64% YoY). Growth was driven by pricing, foreign currency, and volume. Gross margin increased to 33.5%. The company expects mid-20s returns from a new lithium facility in South Carolina, supported by a $150M DoE grant. Q2 guidance: net sales $955M-$995M, adjusted EPS $3.15-$3.25. Management noted risks in the material handling market.

$ENSHighAI 8/10

EnerSys (ENS) Q1 2027 Earnings Call Transcript

EnerSys (ENS) reported Q1 2027 net sales of $935.6M, up 4.8%, and adjusted diluted EPS of $3.66, up 64%. Gross margin increased to 33.5%, driven by pricing and tax credits. The company guided Q2 net sales to $955M-$995M and adjusted EPS to $3.15-$3.25. Management highlighted a $150M DOE grant for a lithium facility and strong demand in data centers and aerospace.